Devonian Health Ownership
| GSD Stock | CAD 0.25 0.01 4.17% |
Shares in Circulation | First Issued 2017-12-31 | Previous Quarter 146.7 M | Current Value 148.2 M | Avarage Shares Outstanding 98.7 M | Quarterly Volatility 34.3 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Devonian |
Devonian Stock Ownership Analysis
About 14.0% of the company shares are held by company insiders. The book value of Devonian Health was currently reported as 0.1. The company recorded a loss per share of 0.01. Devonian Health Group last dividend was issued on the 19th of May 2017. The entity had 1:2 split on the 19th of May 2017. Devonian Health Group Inc., a pharmaceutical company, engages in the development of botanical drugs. The company was incorporated in 2013 and is headquartered in Qubec, Canada. DEVONIAN HEALTH operates under Biotechnology classification in Canada and is traded on TSX Venture Exchange. To learn more about Devonian Health Group call Pierre Montanaro at 514 248 7509 or check out https://groupedevonian.com.Devonian Health Outstanding Bonds
Devonian Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Devonian Health Group uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Devonian bonds can be classified according to their maturity, which is the date when Devonian Health Group has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Devonian Stock Analysis
When running Devonian Health's price analysis, check to measure Devonian Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Devonian Health is operating at the current time. Most of Devonian Health's value examination focuses on studying past and present price action to predict the probability of Devonian Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Devonian Health's price. Additionally, you may evaluate how the addition of Devonian Health to your portfolios can decrease your overall portfolio volatility.